A Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the Brain
A Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the Brain
Active, not recruiting · NCT05892068 · Registry updated 2026-02-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the Brain | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 2 | 2026-02-13 | NCT05892068 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Memorial Sloan Kettering Cancer Center | 753 |
| Pfizer | 431 |
| Seagen Inc. | 31 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Memorial Sloan Kettering Bergen (Limited Protocol Activities) | Montvale | United States | 184 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| Memorial Sloan Kettering Cancer Center (Limited Protocol Activities) | Basking Ridge | United States | 3 |
| Memorial Sloan Kettering Monmouth (Limited Protocol Activities) | Middletown | United States | 186 |
| Memorial Sloan Kettering Nassau (Limited Protocol Activities) | Uniondale | United States | 120 |
| Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) | Commack | United States | 55 |
| Memorial Sloan Kettering Westchester (Limited Protocol Activities) | Harrison | United States | 166 |